Med24
diabetes 30. 9. 2026 • 2 min read • U.S. Food and Drug Administration (OpenFDA)

Pantoprazole Sodium: FDA Clinical Pharmacology, Indications and Prescribing Update

1 INDICATIONS AND USAGE Pantoprazole Sodium for Injection is indicated for treatment of: gastroesophageal reflux disease (GERD) and a history of erosive esophagitis (EE) for up to 10 days in adults. pathological hypersecretory conditions including Zollinger-Ellison (ZE) Syndrome in adults. Pantoprazole Sodium for...

Addressing Post-Intensive Care Syndrome Among Survivors of COVID (APICS-COVID)

Pantoprazole Sodium for Injection is indicated for the treatment of gastroesophageal reflux disease (GERD) and a history of erosive esophagitis (EE) for up to 10 days in adults. It is also indicated for pathological hypersecretory conditions, including Zollinger-Ellison (ZE) Syndrome, in adults.

Mechanism of Action and Clinical Trial Results

The mechanism of action involves covalently binding to the (H + , K + )-ATPase enzyme system, inhibiting gastric acid production irrespective of the stimulus. This results in an antisecretory effect lasting longer than 24 hours at all tested doses (20 mg to 120 mg). A single-dose, open-label, placebo-controlled study demonstrated that, following 10 days of oral administration and 7 days of intravenous administration, the oral and intravenous dosage forms of Pantoprazole Sodium for Injection are similar in their ability to suppress maximum acid output (MAO) and basal acid output (BAO) in patients with GERD and a history of EE. Patients switched to intravenous placebo experienced a significant increase in acid output within 48 hours. However, patients treated with Pantoprazole Sodium for Injection had a significantly lower mean basal acid output at 48 hours compared to the placebo group.

Sponsored content

Recommended Dosage and Considerations

The recommended dosage for GERD with a history of EE is 40 mg once daily by intravenous injection or infusion for up to 10 days. For pathological hypersecretion conditions, including ZE Syndrome, the recommended adult dosage is 80 mg every 12 hours by intravenous injection or infusion. Switching between intravenous and oral formulations should consider the drugs’ pharmacodynamic action to maintain acid suppression. Clinical studies involving 65 patients with a history of EE demonstrated similar efficacy between the intravenous and oral formulations of Pantoprazole Sodium for Injection.

Original Scientific Source
U.S. Food and Drug Administration (OpenFDA)
View Original Source
Medical Disclaimer All calculations, recommendations, and interpretations provided by this tool are for informational and educational purposes only. They do not substitute professional medical advice, diagnosis, or treatment. Always consult your physician regarding any health concerns.

Recommended Medical News

All news →
Advertisement